944916-43-2Relevant articles and documents
Structure-activity relationship (SAR) investigations of substituted imidazole analogs as TRPV1 antagonists
Gore, Vijay K.,Ma, Vu V.,Tamir, Rami,Gavva, Narender R.,Treanor, James J.S.,Norman, Mark H.
, p. 5825 - 5830 (2008/04/03)
A novel series of 4,5-biarylimidazoles as TRPV1 antagonists were designed based on the previously reported 4,6-disubstituted benzimidazole series. The analogs were evaluated for their ability to block capsaicin- or acid-induced calcium influx in TRPV1-expressing CHO cells. These studies led to the identification of a highly potent and orally bioavailable TRPV1 antagonist, imidazole 33.